Catheter Precision Inc
VTAK1.770USD
-0.040-2.21%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
2.92MMarket Cap
0.05P/E TTM
More Details of Catheter Precision Inc Company
Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.
Catheter Precision Inc Info
Ticker SymbolVTAK
Company nameCatheter Precision Inc
IPO dateSep 27, 2018
CEOJenkins (David A)
Number of employees22
Security typeOrdinary Share
Fiscal year-endSep 27
Address1670 Highway 160 West
CityFORT MILL
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code29708
Phone19736912000
Websitehttps://www.ramed.com/
Ticker SymbolVTAK
IPO dateSep 27, 2018
CEOJenkins (David A)
Company Executives of Catheter Precision Inc
Name
Name/Position
Position
Shareholding
Change
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
22.28K
+118.07%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
22.28K
+118.07%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
173.00K
81.60%
All other countries
39.00K
18.40%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Dec 4
Updated: Thu, Dec 4
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Jenkins Family Charitable Institute
2.21%
Jenkins (David A)
1.34%
FatBoy Capital LP
0.22%
Caruso (James Joseph)
0.11%
Manulife Investment Management (North America) Limited
0.03%
Other
96.09%
Shareholders
Shareholders
Proportion
Jenkins Family Charitable Institute
2.21%
Jenkins (David A)
1.34%
FatBoy Capital LP
0.22%
Caruso (James Joseph)
0.11%
Manulife Investment Management (North America) Limited
0.03%
Other
96.09%
Shareholder Types
Shareholders
Proportion
Corporation
2.43%
Individual Investor
1.47%
Investment Advisor
0.03%
Other
96.07%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
23
24.65K
1.66%
-10.09K
2025Q2
30
1.62M
12.88%
+225.25K
2025Q1
34
1.39M
13.16%
+226.78K
2024Q4
37
1.12M
13.97%
-215.80K
2024Q3
45
563.38K
38.63%
+376.14K
2024Q2
46
202.02K
23.51%
+5.34K
2024Q1
50
211.28K
24.77%
+47.42K
2023Q4
52
169.47K
25.10%
+5.69K
2023Q3
56
180.73K
31.24%
+30.19K
2023Q2
57
168.19K
29.83%
+996.00
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Jenkins Family Charitable Institute
36.85K
2.48%
+10.53K
+39.98%
Jun 05, 2025
Jenkins (David A)
10.22K
0.69%
-2.00
-0.02%
Sep 10, 2025
FatBoy Capital LP
3.73K
0.25%
--
--
Jan 29, 2025
Caruso (James Joseph)
1.84K
0.12%
+10.00
+0.55%
Sep 10, 2025
Jenkins (Casey A)
310.00
0.02%
+16.00
+5.44%
Jun 05, 2025
Jenkins Linda A
12.00
0%
--
--
Jan 29, 2025
BofA Global Research (US)
6.00
0%
+2.00
+50.00%
Jun 30, 2025
Harbour Investments, Inc
8.00
0%
--
--
Jun 30, 2025
SBI Securities Co., Ltd.
58.00
0%
+58.00
--
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jul 28, 2025
Merger
19→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Sep 21, 2022
Merger
50→1
Date
Type
Ratio
Jul 28, 2025
Merger
19→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Jul 03, 2024
Merger
10→1
Sep 21, 2022
Merger
50→1
Sep 21, 2022
Merger
50→1
Sep 21, 2022
Merger
50→1
Sep 21, 2022
Merger
50→1
Nov 16, 2020
Merger
25→1
View more
FAQs
Who are the top five shareholders of Catheter Precision Inc?
The top five shareholders of Catheter Precision Inc are:
Jenkins Family Charitable Institute holds 36.85K shares, accounting for 2.48% of the total shares.
Jenkins (David A) holds 10.22K shares, accounting for 0.69% of the total shares.
FatBoy Capital LP holds 3.73K shares, accounting for 0.25% of the total shares.
Caruso (James Joseph) holds 1.84K shares, accounting for 0.12% of the total shares.
Jenkins (Casey A) holds 310.00 shares, accounting for 0.02% of the total shares.
Jenkins Family Charitable Institute holds 36.85K shares, accounting for 2.48% of the total shares.
Jenkins (David A) holds 10.22K shares, accounting for 0.69% of the total shares.
FatBoy Capital LP holds 3.73K shares, accounting for 0.25% of the total shares.
Caruso (James Joseph) holds 1.84K shares, accounting for 0.12% of the total shares.
Jenkins (Casey A) holds 310.00 shares, accounting for 0.02% of the total shares.
What are the top three shareholder types of Catheter Precision Inc?
The top three shareholder types of Catheter Precision Inc are:
Jenkins Family Charitable Institute
Jenkins (David A)
FatBoy Capital LP
Jenkins Family Charitable Institute
Jenkins (David A)
FatBoy Capital LP
How many institutions hold shares of Catheter Precision Inc (VTAK)?
As of 2025Q3, 23 institutions hold shares of Catheter Precision Inc, with a combined market value of approximately 24.65K, accounting for 1.66% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -11.22%.
What is the biggest source of revenue for Catheter Precision Inc?
In FY2025Q2, the -- business generated the highest revenue for Catheter Precision Inc, amounting to -- and accounting for --% of total revenue.
